Albert Bourla elected to Pfizer’s board of directors
Pfizer announced the election of Albert Bourla, DVM, Ph.D. to its Board of Directors. Dr. Bourla is currently the COO of Pfizer. Prior to assuming the role of COO in 2018, he was the Group President of Pfizer Innovative Health, responsible for the Consumer Healthcare, Inflammation and Immunology. February 23, 2018